Cargando…
Long-Term Biocompatibility of a Highly Viscously Thiol-Modified Cross-Linked Hyaluronate as a Novel Vitreous Body Substitute
Purpose: In surgical ophthalmology, the treatment of complicated retinal and vitreous diseases is one of the central challenges. For this purpose, the vitreous body is removed as part of the standard therapy and replaced by a temporary tamponade to stabilize the position of the retina. Since the tam...
Autores principales: | Hurst, Jose, Rickmann, Annekatrin, Heider, Nele, Hohenadl, Christine, Reither, Charlotte, Schatz, Andreas, Schnichels, Sven, Januschowski, Kai, Spitzer, Martin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924550/ https://www.ncbi.nlm.nih.gov/pubmed/35308238 http://dx.doi.org/10.3389/fphar.2022.817353 |
Ejemplares similares
-
Ex vivo biophysical characterization of a hydrogel-based artificial vitreous substitute
por: Januschowski, Kai, et al.
Publicado: (2019) -
Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment
por: Schnichels, Sven, et al.
Publicado: (2017) -
Alginate- and Hyaluronic Acid–Based Hydrogels as Vitreous Substitutes: An In Vitro Evaluation
por: Schulz, André, et al.
Publicado: (2020) -
An Unusual Case of DMEK Graft Loss into the Vitreous and Its Successful Retrieval and Survival
por: Helaiwa, Khaled, et al.
Publicado: (2018) -
Context-sensitive smart glasses monitoring wear position and activity for therapy compliance—A proof of concept
por: Januschowski, Kai, et al.
Publicado: (2021)